In this issue
The mystery of transfusion-related acute lung injury
Who benefits from red blood cell salvage?—Utility and value of intraoperative autologous transfusion
The quest to reduce vasovagal reactions in young blood donors
Arming for war: the donor's arm
How do we manage patients treated with antithrombotic therapy in the perioperative interval
The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody–positive or –negative components
Establishing assay cutoffs for HLA antibody screening of apheresis donors
Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008
Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study
Molecular relatedness of Propionibacterium species isolated from blood products and on the skin of blood donors
Continuing Medical Education Program in Transfusion
The volume of returned red blood cells in a large blood salvage program: where does it all go? (CME)
Blood management in pediatric spinal deformity surgery: review of a 2-year experience
Nucleotide deletion in RHCE * cE (907delC) is responsible for a D− – haplotype in Hispanics
Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients
Epitope mapping of antibodies directed against the human neutrophil alloantigen 3a
HNA-3a–specific antibodies recognize choline transporter–like protein-2 peptides containing arginine, but not glutamine at Position 154
Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics
The value of routine ferritin measurement in blood donors
A comparison of self-reported and record-linked blood donation history in an Australian cohort
Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method
Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment
Validation of a microbial detection system for use with ACD-A platelets with PAS III platelet additive solution
Infusion of P-Capt prion-filtered red blood cell products demonstrate acceptable in vivo viability and no evidence of neoantigen formation
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency
Intraoperative cell salvage in obstetrics: is it a real therapeutic option?
Postthaw filtration of umbilical cord blood does not affect product quality or likelihood of engraftment
The role of the pretransfusion platelet count in platelet refractoriness
Blood transfusion and the microcirculation